KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based CompensationShares IssuedShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Idexx Laboratories (IDXX) Free Cash Flow (2016 - 2025)

Idexx Laboratories has reported Free Cash Flow over the past 17 years, most recently at $326.3 million for Q4 2025.

  • Quarterly results put Free Cash Flow at $326.3 million for Q4 2025, up 115.39% from a year ago — trailing twelve months through Dec 2025 was $1.1 billion (up 30.82% YoY), and the annual figure for FY2025 was $1.1 billion, up 30.82%.
  • Free Cash Flow for Q4 2025 was $326.3 million at Idexx Laboratories, down from $371.2 million in the prior quarter.
  • Over the last five years, Free Cash Flow for IDXX hit a ceiling of $371.2 million in Q3 2025 and a floor of $44.3 million in Q4 2022.
  • Median Free Cash Flow over the past 5 years was $180.9 million (2021), compared with a mean of $183.4 million.
  • Biggest five-year swings in Free Cash Flow: soared 757.07% in 2021 and later plummeted 62.17% in 2022.
  • Idexx Laboratories' Free Cash Flow stood at $105.1 million in 2021, then plummeted by 57.92% to $44.3 million in 2022, then skyrocketed by 391.05% to $217.3 million in 2023, then tumbled by 30.28% to $151.5 million in 2024, then skyrocketed by 115.39% to $326.3 million in 2025.
  • The last three reported values for Free Cash Flow were $326.3 million (Q4 2025), $371.2 million (Q3 2025), and $132.3 million (Q2 2025) per Business Quant data.